The late Sir Allen McClay set up this pharmaceuticals developer in 2001. Almac provides research, development and commercialisation services to more than 600 drug companies. Based in Craigavon in Northern Ireland, it also has a large US operation. Alan Armstrong, 55, is chairman and chief executive.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyAlmac Group
ActivityPharmaceuticals maker
LocationCraigavon, Co Armagh
Sales £m325.3
Operating profit £m21.6
Main shareholdersMcClay Foundation (100%)

If applicable:

* supplied by Company   † annualised figure   ‡  profit = ebitda